The microglial P2Y6 receptor mediates neuronal loss and memory deficits in neurodegeneration
Year: 2021
Type: article
Abstract: Microglia are implicated in neurodegeneration, potentially by phagocytosing neurons, but it is unclear how to block the detrimental effects of microglia while preserving their beneficial roles. The microglial P2Y 6 receptor (P2Y 6 R) – activated by extracellular UDP released by stressed neurons – is required for microglial phagocytosis of neurons. We show here that injection of amyloid beta (Aβ) into mouse brain induces microglial phagocytosis of neurons, followed by neuronal and memory loss, and this is all prevented by knockout of P2Y 6 R. In a chronic tau model of neurodegeneration (P301S TAU mice), P2Y 6 R knockout prevented TAU-induced neuronal and memory loss. In vitro , P2Y 6 R knockout blocked microglial phagocytosis of live but not dead targets and reduced tau-, Aβ-, and UDP-induced neuronal loss in glial-neuronal cultures. Thus, the P2Y 6 receptor appears to mediate Aβ- and tau-induced neuronal and memory loss via microglial phagocytosis of neurons, suggesting that blocking this receptor may be beneficial in the treatment of neurodegenerative diseases.
Source: Cell Reports
Language: English
Subfield: Neurology
Field: Neuroscience
Domain: Life Sciences
Open Access status: gold
Estimated APC paid: $5,200
Funders: Eli Lilly and Company, Wellcome Trust, LifeArc, European Federation of Pharmaceutical Industries and Associations, European Commission, Alzheimer’s Research UK, Innovative Medicines Initiative, Horizon 2020 Framework Programme, Medical Research Council, Biotechnology and Biological Sciences Research Council
Awards: G1268142771, The roles of microglial phagocytosis in ageing-induced synaptic neuronal and memory loss, G339059223, Microglial phagocytic receptors P2Y6 & VNR in brain pathology and therapy, G4045232399, G434337789, Microglial interactions with neurons in health, ageing and neurodegeneration, G545722411, The University of Cambridge Metabolic Research Laboratories, Wellcome-MRC Institute of Metabolic Science, Cambridge, The University of Cambridge Metabolic Research Laboratories, Wellcome Trust-MRC Institute of Metabolic Science, Cambridge, Inflammation and AD: modulating microglia function focussing on TREM2 and CD33 - Sofia ref.: 115976, G8867773287
OpenAlex ID: W4200118966
